Resumen de acción

Trading at 81.6% below our estimate of its fair value

Earnings are forecast to grow 20.53% per year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 30.9%

Profit margins (5.4%) are lower than last year (11.3%)

Dividend of 2.22% is not well covered

Significant insider selling over the past 3 months

No hay actualizaciones

No hay actualizaciones

	0NPP	Chemicals	Mercado
7D	0.2%	0%	0%
1Y	-28.1%	0%	0%

Rentabilidad vs. Industria: 0NPP underperformed the UK Chemicals industry which returned -20.3% over the past year.

Rentabilidad vs. Mercado: 0NPP underperformed the UK Market which returned -6.2% over the past year.

Is 0NPP's price volatile compared to industry and market?
0NPP volatility
0NPP Average Weekly Movement	2.8%
Chemicals Industry Average Movement	0%
Market Average Movement	0%
10% most volatile stocks in GB Market	0%
10% least volatile stocks in GB Market	0%

Precio estable de las acciones: 0NPP has not had significant price volatility in the past 3 months.

Volatilidad a lo largo del tiempo: 0NPP's weekly volatility (3%) has been stable over the past year.

Fundada	Empleados	CEO	Página web
1902	19,973	Dimitri de Vreeze	n/a

¿Cómo se comparan los beneficios e ingresos de DSM-Firmenich con su capitalización de mercado?
Estadísticas fundamentales de 0NPP
Capitalización bursátil	n/a
Beneficios(TTM)	0
Ingresos (TTM)	n/a

Ratio precio-beneficio (PE)

Ratio precio-ventas (PS)

¿Está 0NPP sobrevalorada?

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 0NPP
Ingresos	US$8.39b
Coste de los ingresos	US$5.70b
Beneficio bruto	US$2.69b
Otros gastos	US$2.24b
Beneficios	US$454.00m

Últimos beneficios comunicados

n/a

Próxima fecha de beneficios

n/a

¿Cómo se ha desempeñado 0NPP a largo plazo?